Eli Lilly COVID-19 drug combo cuts risk of hospitalizations, deaths by 87%: study

A combination of two Eli Lilly antibody drugs cut the risk of COVID-19-related hospitalizations and deaths by 87%, the company announced Wednesday, further upholding dosing already authorized by the Food and Drug Administration.

from FOX News https://ift.tt/38rGarq